Objective:
To review the 2026 Medicare changes affecting ophthalmology ASCs and outline specific strategies for optimizing reimbursement, including operational adjustments and documentation improvements.
Approach:
- CMS's 2026 updates include a 2.4% payment increase for ASC facility services, which may impact overall financial health.
- Expansion of the ASC Covered Procedures List (ASC-CPL) allows more ophthalmic procedures to be performed in ASCs, potentially increasing case volume.
- Ophthalmology has a strong safety record in ASCs, supporting the migration of procedures from HOPDs, which can enhance patient access.
- Changes in the Medicare Physician Fee Schedule (PFS) affect RVUs and practice expenses unevenly across ophthalmology, necessitating careful financial planning.
- Increased prior authorization requirements add to administrative workload for ophthalmology practices, highlighting the need for efficient documentation processes.
- Final additions to the ASC-CPL are pending confirmation in the Final Rule, which may affect planning and implementation timelines.
- The impact of RVU revaluations may vary significantly among different ophthalmic procedures, requiring tailored financial strategies.
Key Findings:
Interpretation:
Ophthalmology practices must adapt to regulatory changes to maintain financial stability and patient access, particularly through the expanded ASC-CPL and evolving reimbursement structures, by implementing strategic operational changes.
Limitations:
Conclusion:
Proactive adaptation to the 2026 Medicare changes is essential for ophthalmology practices to optimize their operational and financial strategies.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.